Swine Healthcare Market – Global Industry Size, Share, Trend, Opportunity & Forecast, Segmented By Type (Diagnostics, Therapeutics), By Disease (Exudative dermatitis (greasy pig disease), Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, Other), By Region and Competition, 2019-2029F
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationSwine Healthcare Market – Global Industry Size, Share, Trend, Opportunity & Forecast, Segmented By Type (Diagnostics, Therapeutics), By Disease (Exudative dermatitis (greasy pig disease), Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, Other), By Region and Competition, 2019-2029F
Forecast Period | 2025-2029 |
Market Size (2023) | USD 2.82 billion |
Market Size (2029) | USD 4.51 billion |
CAGR (2024-2029) | 8.30% |
Fastest Growing Segment | Therapeutics |
Largest Market | North America |
Download Sample Ask for Discount Request Customization
Market Overview
Global Swine Healthcare Market was valued at USD 2.82 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 8.30% through 2029.
Swine Healthcare are designed to enhance the regular diet by providing individuals with the necessary daily nutritional value. Vitamins play crucial roles in the development and proper functioning of the body, acting as hormones, coenzymes, and antioxidants. Various factors such as shifting dietary preferences, busy lifestyles, rising employment rates, and increased awareness of the health benefits associated with Swine Healthcare are expected to positively influence the global market growth.
Due to hectic schedules, many individuals struggle to maintain a balanced diet, resulting in nutrient deficiencies. Consequently, there has been a significant rise in the consumption of Swine Healthcare to fulfil daily nutrient and vitamin requirements, promoting overall health and vitality. The increasing healthcare expenditure worldwide is anticipated to drive the demand for Swine Healthcare. The growing elderly population in both developed and developing economies presents lucrative opportunities for market players in the forecast period. The senior population relies on Swine Healthcare to meet their dietary needs, promote bone health, and support overall well-being.
Key Market Drivers
Increasing Demand for Pork Products
The increasing demand for pork products is a significant driver propelling the growth of the global swine healthcare market. This demand surge is attributed to several factors, including population growth, rising disposable incomes, urbanization, and changing dietary preferences, particularly in emerging economies.
As the global population continues to expand, especially in regions such as Asia and Africa, there is a corresponding increase in the demand for protein-rich foods, with pork being a favored choice due to its affordability, versatility, and nutritional value. Urbanization and economic development lead to dietary shifts towards higher protein consumption, further fueling the demand for pork products.
The growing affluence in emerging economies translates into higher purchasing power and increased consumption of animal protein, including pork. This trend is particularly pronounced in countries experiencing rapid urbanization and transitioning dietary patterns, where pork is often considered a staple protein source in traditional cuisines.
The versatility of pork makes it a popular choice across diverse culinary cultures, contributing to its widespread consumption globally. From traditional dishes to modern cuisines, pork products feature prominently in a wide range of culinary applications, driving sustained demand in both domestic and international markets.
As the demand for pork products continues to rise, swine producers face the challenge of meeting consumer expectations for safe, high-quality pork while ensuring the health and welfare of their livestock. This underscores the importance of investing in swine healthcare solutions to prevent diseases, enhance productivity, and meet the growing demand for pork products in a competitive global market.
Rising Technological Advancements in Healthcare Solutions
Technological advancements in healthcare solutions are playing a pivotal role in driving the growth of the global swine healthcare market. These advancements encompass a wide range of innovations, including diagnostic tools, treatment modalities, digital health technologies, and precision farming solutions, all aimed at improving swine health, productivity, and welfare.
One of the key areas of technological innovation in swine healthcare is in disease diagnostics. Advanced diagnostic tools, such as polymerase chain reaction (PCR) assays, enzyme-linked immunosorbent assays (ELISA), and next-generation sequencing (NGS) technologies, enable rapid and accurate identification of pathogens responsible for infectious diseases in swine. Early detection of diseases allows for timely intervention and targeted treatment, minimizing the spread of infections and reducing economic losses for swine producers.
Advancements in vaccine development and delivery systems have revolutionized disease prevention strategies in swine farming. Next-generation vaccines, including recombinant vaccines, vectored vaccines, and subunit vaccines, offer improved efficacy, safety, and convenience compared to traditional vaccine formulations. Novel delivery systems, such as oral vaccines and intranasal vaccines, enhance vaccine uptake and stimulate robust immune responses in swine populations, thereby reducing the incidence and severity of infectious diseases.
Digital health technologies are also driving innovation in swine healthcare by enabling real-time monitoring, data analytics, and predictive modeling capabilities. Internet of Things (IoT) devices, wearable sensors, and smart monitoring systems allow swine producers to remotely monitor key health parameters, such as body temperature, feed intake, and activity levels, facilitating early detection of health issues and proactive management interventions. Data-driven insights derived from these technologies help optimize management practices, enhance operational efficiency, and improve decision-making across the swine production chain.
Precision farming solutions harness the power of automation, robotics, and artificial intelligence (AI) to optimize resource utilization, minimize environmental impact, and maximize productivity in swine production systems. Automated feeding systems, environmental control systems, and robotic husbandry devices streamline farm operations, reduce labor costs, and ensure consistent quality standards, thereby contributing to the overall health and well-being of swine populations.
Increase in Regulatory Pressure to Reduce Antimicrobial Use
Regulatory pressure to reduce antimicrobial use is a significant driver boosting the global swine healthcare market, catalyzing innovation, and fostering adoption of alternative healthcare solutions aimed at ensuring swine health and welfare while mitigating the risk of antimicrobial resistance (AMR). This pressure stems from growing concerns over the emergence of AMR, which poses a serious threat to both animal and human health, necessitating concerted efforts to curb the overuse and misuse of antimicrobial agents in livestock production, including swine farming.
Regulatory agencies worldwide have implemented policies and guidelines to promote responsible antimicrobial use in swine production, imposing restrictions on the use of medically important antibiotics as growth promoters and advocating for prudent use practices in disease prevention and treatment. This regulatory landscape drives the need for alternative healthcare strategies that reduce reliance on antibiotics while maintaining effective disease management outcomes.
In response to regulatory pressure, swine producers are increasingly embracing preventive healthcare measures, such as vaccination programs, biosecurity protocols, and nutritional interventions, to enhance swine health and minimize the need for antimicrobial treatments. There is growing interest in alternative products and strategies, including probiotics, prebiotics, immunomodulators, and phytogenics, which promote gut health, boost immunity, and support overall swine well-being without contributing to AMR.
Advancements in diagnostic technologies enable early detection of diseases, facilitating targeted treatment interventions and reducing the necessity for broad-spectrum antimicrobial use. Rapid diagnostic tests, molecular assays, and point-of-care devices empower swine producers to make informed treatment decisions, optimize antimicrobial use, and minimize the risk of AMR emergence.
Key Market Challenges
Disease Outbreaks
One of the most significant challenges that has consistently hampered the growth of the global Swine Healthcare market is the occurrence of disease outbreaks. Swine diseases, such as African Swine Fever (ASF), Porcine Epidemic Diarrhea Virus (PEDv), and Foot-and-Mouth Disease (FMD), have wreaked havoc on swine populations across the world. These outbreaks not only lead to substantial economic losses but also threaten global food security due to reduced pork production.
The rapid spread of diseases is facilitated by factors such as global trade, travel, and inadequate biosecurity measures. The impact of these outbreaks is multi-faceted, affecting pig farmers, feed manufacturers, veterinarians, and the entire pork supply chain. The need for robust disease surveillance, early detection, and effective containment strategies is paramount to mitigate the adverse effects of disease outbreaks., ultimately impacting market growth in the forecast period.
Download Sample Ask for Discount Request Customization
Regulatory Hurdles
The global Swine Healthcare market operates within a complex regulatory landscape that presents significant hurdles. Regulatory frameworks vary across countries and regions, impacting disease management, genetic research, and trade practices. These regulations influence the movement of live animals, vaccines, and genetic materials, directly affecting the growth of the industry.
Navigating these regulatory hurdles requires a deep understanding of country-specific requirements, import-export regulations, and compliance standards. The time and resources spent on ensuring regulatory adherence can impede the pace of innovation and hinder the adoption of advanced technologies.
Consumer Perception and Sustainability Demands
In recent years, consumer awareness and concerns regarding animal welfare, environmental impact, and antibiotic use have grown significantly. This shift in consumer perception has led to increased demand for sustainable and ethically produced pork products. Meeting these demands while ensuring Swine Healthcare presents a unique challenge for the industry.
Striking a balance between sustainable practices, animal welfare, and efficient production requires innovative approaches. Reducing the use of antibiotics, implementing environmentally friendly waste management systems, and adopting animal-friendly housing are essential steps to address consumer demands. However, these transitions often require substantial investments, retraining of industry professionals, and changes in traditional practices.
Key Market Trends
Increasing Focus on Preventive Healthcare
The increasing focus on preventive healthcare is a significant driver propelling the growth of the global swine healthcare market. This shift in approach reflects a proactive stance aimed at preventing diseases before they occur, rather than solely relying on reactive treatment measures. Several factors contribute to the rising emphasis on preventive healthcare in the swine industry.
The intensification of swine farming practices has heightened the risk of disease outbreaks due to increased stocking densities, environmental stressors, and transmission pathways. In response, swine producers are prioritizing preventive measures to minimize the introduction and spread of pathogens within their herds. This includes implementing stringent biosecurity protocols, vaccination programs, and hygiene practices to reduce the risk of disease transmission and maintain herd health.
The emergence of antimicrobial resistance (AMR) has prompted regulatory agencies and industry stakeholders to advocate for responsible antimicrobial use in livestock production, including swine farming. As a result, there is a growing recognition of the importance of preventive healthcare strategies, such as vaccination, nutrition optimization, and environmental management, in reducing the reliance on antibiotics and preserving their effectiveness for therapeutic use.
The economic implications of disease outbreaks in swine populations underscore the importance of investing in preventive healthcare measures. Disease outbreaks can result in significant production losses, including decreased growth rates, reduced feed conversion efficiency, and increased mortality rates, leading to financial strain for swine producers. By prioritizing preventive healthcare, producers can mitigate the risk of disease-related losses and optimize the profitability and sustainability of their operations.
Advancements in diagnostic technologies enable early detection of diseases and proactive management interventions, further driving the adoption of preventive healthcare practices in the swine industry. Real-time monitoring systems, rapid diagnostic tests, and data analytics tools empower producers to identify health issues before they escalate, allowing for timely intervention and optimized treatment protocols.
Adoption of Digital Health Solutions
The adoption of digital health solutions is playing a pivotal role in driving growth in the global swine healthcare market, revolutionizing the way swine producers monitor, manage, and optimize the health and productivity of their livestock. Digital health solutions encompass a wide range of technologies, including IoT-enabled devices, wearable sensors, data analytics platforms, and precision farming systems, all aimed at enhancing efficiency, sustainability, and profitability in swine production.
One of the key drivers of the adoption of digital health solutions is the need for real-time monitoring and early detection of health issues in swine populations. IoT-enabled devices and wearable sensors allow swine producers to remotely monitor key health parameters such as body temperature, feed intake, and activity levels, providing valuable insights into the health status and well-being of individual animals and entire herds. This real-time monitoring capability enables early detection of health issues, prompt intervention, and optimized treatment protocols, ultimately improving overall herd health and productivity.
Digital health solutions enable data-driven decision-making and performance optimization across the swine production chain. Advanced data analytics platforms process and analyze large volumes of data generated from various sources, including environmental sensors, production records, and health monitoring devices, to provide actionable insights into farm operations and management practices. By leveraging these insights, swine producers can identify trends, predict outcomes, and implement targeted interventions to improve efficiency, reduce costs, and maximize profitability.
Precision farming systems represent another aspect of digital health solutions that are driving innovation in the swine healthcare market. These systems utilize automation, robotics, and artificial intelligence (AI) to optimize resource utilization, minimize environmental impact, and maximize productivity in swine production systems. Automated feeding systems, environmental control systems, and robotic husbandry devices streamline farm operations, reduce labor costs, and ensure consistent quality standards, contributing to improved efficiency and sustainability.
The adoption of digital health solutions is transforming the global swine healthcare market by enabling proactive disease management, data-driven decision-making, and precision farming practices. As swine producers recognize the value of digital technologies in optimizing health, productivity, and profitability, investment in digital health solutions is expected to continue to grow, driving innovation and market expansion in the swine healthcare sector.
Segmental Insights
Download Sample Ask for Discount Request Customization
Type Insights
In 2023, the therapeutics segment emerged as the dominant within the global market for Swine Healthcare. This dominance can be attributed to the increasing prevalence of diseases among swine populations worldwide, driving demand for effective treatment options. Therapeutics encompass a wide range of pharmaceutical products, including antibiotics, vaccines, antiparasitic drugs, and other medications aimed at preventing, controlling, and treating various diseases and health conditions in swine. Regulatory pressure to reduce antimicrobial use has fueled the development and adoption of alternative therapeutic strategies, such as probiotics, immunomodulators, and herbal remedies, further contributing to the growth of the therapeutics segment. As swine producers prioritize the health and welfare of their livestock, investment in therapeutic interventions remains a key focus area, driving innovation and market expansion in the global Swine Healthcare market.
Disease Insights
Based on the category of Disease, the respiratory diseases segment emerged as the dominant in the global market for Swine Healthcare in 2023.
Respiratory diseases often present with acute symptoms that rapidly spread among swine populations. The highly contagious nature of many respiratory pathogens, coupled with the close quarters of commercial swine facilities, facilitates rapid disease transmission. Once launched to a farm, these diseases can quickly escalate into widespread outbreaks, causing a surge in morbidity and mortality rates.
Regional Insights
North America emerges as a dominating force in the global Swine Healthcare market, driven by its advanced agricultural practices, robust infrastructure, and well-established veterinary healthcare systems. Countries such as the United States and Canada are at the forefront of swine production and health management, contributing significantly to the market's growth and innovation.
Recent Developments
- In January 2024, MSD Animal Health, a division of Merck & Co., Inc.,disclosed that CIRCUMVENT CML has clinched the title of Best New Food AnimalProduct from S&P Global Animal Health. CIRCUMVENT CML represents agroundbreaking advancement as the inaugural and sole ready-to-use, single-doseintramuscular injectable vaccine designed to combat diseases triggered byPorcine Circovirus Types 2a and 2d, Mycoplasma hyopneumoniae, and Lawsoniaintracellularis in pigs aged three weeks or older.
Key Market Players
- BoehringerIngelheim International GmbH
- Ceva Santé Animale
- Elanco AnimalHealth Incorporated
- InnovativeDiagnostics
- Merck KgaA
- Vetoquinol SA
- Virbac S.A.
- Zoetis Inc.
- IDEXXLaboratories, Inc
- PhibroAnimal Health Corporation
By Type |
By Disease |
By Region |
|
|
|
Table of Content
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation And Scope
1.1.1 Regional Scope
1.1.2 Estimates And Forecast Timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4. Information/Data Analysis
1.4.1 Information Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.8. List Of Secondary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Insights Snapshot
Chapter 3. Swine Vaccines Market Variables, Trends, and Scope
3.1. Market Lineage
3.1.1. Parent Market Analysis
3.1.2. Ancillary Market Analysis
3.2. Swine Vaccines Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising concern about zoonoses & strengthening biosecurity
3.2.1.2. Vaccines act as an alternative to antibiotics
3.2.1.3. Technological advancements
3.2.1.4. Regulatory mandates
3.2.2. Market Restraint Analysis
3.2.2.1. Short product exclusivity period
3.2.2.2. Religious and cultural restrictions
3.2.2.3. Supply bans on live pigs and pork products
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenges Analysis
3.3. Swine Vaccines Market: Porter’s 5 Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Suppliers
3.3.5. Competitive Rivalry
3.4. Swine Vaccines Market: PESTLE Analysis
3.4.1. Political Landscape
3.4.2. Economic Landscape
3.4.3. Social Landscape
3.4.4. Technology Landscape
3.4.5. Legal Landscape
3.4.6. Environmental Landscape
3.5. Regulatory Landscape
3.6. Product Pipeline Analysis
3.7. Covid-19 Analysis
3.8. Estimated Pig population by key countries, 2018 to 2022
Chapter 4. Product Estimates & Trend Analysis, 2018 - 2030 (USD Million)
4.1. Swine Vaccines Market By Product: Key Takeaways
4.2. Product Movement Analysis & Market Share, 2022 & 2030
4.3. Swine Vaccines Market Estimates & Forecast, By Product (USD Million)
4.4. Attenuated Live Vaccines
4.4.1. Attenuated Live Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.5. Inactivated Vaccines
4.5.1. Inactivated Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.6. Subunit Vaccines
4.6.1. Subunit Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.7. DNA Vaccines
4.7.1. DNA Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.8. Recombinant Vaccines
4.8.1. Recombinant Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Type Estimates & Trend Analysis, 2018 - 2030 (USD Million)
5.1. Swine Vaccines Market By Type: Key Takeaways
5.2. Type Movement Analysis & Market Share, 2022 & 2030
5.3. Swine Vaccines Market Estimates & Forecast, By Type (USD Million)
5.4. Swine Influenza
5.4.1. Swine Influenza Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5. Classical Swine Fever
5.5.1. Classical Swine Fever Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6. Porcine Parvovirus
5.6.1. Porcine Parvovirus Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.7. Porcine Circovirus Type 2
5.7.1. Porcine Circovirus Type 2 Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.8. M.Hyo
5.8.1. M.Hyo Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.9. Actinobacillus Pleuropneumonia
5.9.1. Actinobacillus Pleuropneumonia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.10. PRRS
5.10.1. PRRS Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.11. Foot & Mouth Disease
5.11.1. Foot & Mouth Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.12. Pseudorabies
5.12.1. Pseudorabies Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.13. Porcine Epidemic Diarrhea
5.13.1. Porcine Epidemic Diarrhea Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.14. Others
5.14.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Regional Estimates & Trend Analysis, 2018 - 2030 (USD Million)
6.1. Regional Outlook
6.2. Regional Marketplace, Key Takeaways
6.3. North America
6.3.1. Swot Analysis
6.3.2. North America Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. U.S.
6.3.3.1. Key Country Dynamics
6.3.3.2. U.S. Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. Canada
6.3.4.1. Key Country Dynamics
6.3.4.2. Canada Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Swot Analysis
6.4.2. Europe Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Germany Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. UK
6.4.4.1. Key Country Dynamics
6.4.4.2. UK Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. France
6.4.5.1. Key Country Dynamics
6.4.5.2. France Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Spain Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Italy
6.4.7.1. Key Country Dynamics
6.4.7.2. Italy Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Swot Analysis
6.5.2. Asia Pacific Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Japan
6.5.3.1. Key Country Dynamics
6.5.3.2. Japan Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. China
6.5.4.1. Key Country Dynamics
6.5.4.2. China Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.5. India
6.5.5.1. Key Country Dynamics
6.5.5.2. India Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.6. Australia
6.5.6.1. Key Country Dynamics
6.5.6.2. Australia Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.7. South Korea
6.5.7.1. Key Country Dynamics
6.5.7.2. South Korea Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Latin America Swot Analysis
6.6.2. Latin America Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Brazil
6.6.3.1. Key Country Dynamics
6.6.3.2. Brazil Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. Mexico
6.6.4.1. Key Country Dynamics
6.6.4.2. Mexico Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Argentina
6.6.5.1. Key Country Dynamics
6.6.5.2. Argentina Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. MEA Swot Analysis
6.7.2. MEA Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. South Africa
6.7.3.1. Key Country Dynamics
6.7.3.2. South Africa Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.4. Saudi Arabia
6.7.4.1. Key Country Dynamics
6.7.4.2. Saudi Arabia Swine Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Key Company Profiles
• Merck & Co., Inc.
• Ceva
• Zoetis
• Boehringer Ingelheim International GmbH
• Elanco
• Indian Immunologicals Ltd.
• Biogénesis Bagó
• Phibro Animal Health Corporation
• HIPRA
• Virbac
7.2.1. Participant’s Overview
7.2.2. Products Benchmarking
7.2.3. Financial Performance
7.2.4. Strategy Mapping
7.3. List Of Key Companies
7.4. Company Market Position Analysis
List of Tables
Table 1 List of secondary sources
Table 2 List of key companies
Table 3 Global Swine Vaccines Market, by region, 2018 - 2030 (USD Million)
Table 4 Global Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 5 Global Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 6 North America Swine Vaccines Market, by country, 2018 - 2030 (USD Million)
Table 7 North America Swine Vaccines Market, by Products, 2018 - 2030 (USD Million)
Table 8 North America Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 9 U.S. Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 10 U.S. Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 11 Canada Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 12 Canada Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 13 Europe Swine Vaccines Market, by country, 2018 - 2030 (USD Million)
Table 14 Europe Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 15 Europe Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 16 Germany Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 17 Germany Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 18 U.K. Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 19 U.K. Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 20 France Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 21 France Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 22 Italy Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 23 Italy Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 24 Spain Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 25 Spain Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 26 Asia Pacific Swine Vaccines Market, by country, 2018 - 2030 (USD Million)
Table 27 Asia Pacific Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 29 Japan Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 30 Japan Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 31 China Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 32 China Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 33 India Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 34 India Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 35 Australia Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 36 Australia Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 37 South Korea Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 38 South Korea Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 39 LATAM Swine Vaccines Market, by country, 2018 - 2030 (USD Million)
Table 40 LATAM Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 41 LATAM Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 42 Brazil Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 43 Brazil Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 44 Mexico Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 45 Mexico Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 46 Argentina Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 47 Argentina Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 48 MEA Swine Vaccines Market, by country, 2018 - 2030 (USD Million)
Table 49 MEA Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 50 MEA Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 51 South Africa Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 52 South Africa Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 53 Saudi Arabia Swine Vaccines Market, by Product, 2018 - 2030 (USD Million)
Table 54 Saudi Arabia Swine Vaccines Market, by Type, 2018 - 2030 (USD Million)
Table 55 Company Overview
Table 56 Financial Performance
Table 57 Product Benchmarking
Table 58 Strategic Initiatives
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Parent Market Analysis
Fig. 10 Commodity flow analysis
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Competitive landscape snapshot
Fig. 14 Swine Vaccines Market Dynamics
Fig. 15 Swine Vaccines Market: PORTER’s Analysis
Fig. 16 Swine Vaccines Market PESTLE Analysis
Fig. 17 Swine Vaccines Market: Product movement analysis
Fig. 18 Swine Vaccines Market: Product Key takeaways
Fig. 19 Global Attenuated Live Vaccines market 2018 - 2030 (USD Million)
Fig. 20 Global Inactivated Vaccines market 2018 - 2030 (USD Million)
Fig. 21 Global Subunit Vaccines market 2018 - 2030 (USD Million)
Fig. 22 Global DNA Vaccines market 2018 - 2030 (USD Million)
Fig. 23 Global Recombinant Vaccines market 2018 - 2030 (USD Million)
Fig. 24 Swine Vaccines Market: Type movement analysis
Fig. 25 Swine Vaccines Market: Type Key takeaways
Fig. 26 Global Swine Influenza market 2018 - 2030 (USD Million)
Fig. 27 Global Classical Swine Fever market 2018 - 2030 (USD Million)
Fig. 28 Global Porcine Parvovirus market 2018 - 2030 (USD Million)
Fig. 29 Global Porcine Circovirus Type 2 market 2018 - 2030 (USD Million)
Fig. 30 Global M.Hyo market 2018 - 2030 (USD Million)
Fig. 31 Global Actinobacillus Pleuropneumonia market 2018 - 2030 (USD Million)
Fig. 32 Global PRRS market 2018 - 2030 (USD Million)
Fig. 33 Global Foot & Mouth Disease market 2018 - 2030 (USD Million)
Fig. 34 Global Pseudorabies market 2018 - 2030 (USD Million)
Fig. 35 Global Porcine Epidemic Diarrhea market 2018 - 2030 (USD Million)
Fig. 36 Global Others market 2018 - 2030 (USD Million)
Fig. 37 Regional outlook, 2022 & 2030
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 North America Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 40 U.S. Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 41 Canada Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 42 Europe Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 43 Germany Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 44 U.K. Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 45 France Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 46 Italy Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 47 Spain Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 48 Asia Pacific Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 49 China Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 50 Japan Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 51 India Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 52 Australia Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 53 South Korea Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 54 Latin America Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 55 Brazil Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 56 Mexico Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 57 Argentina Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 58 MEA Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 59 South Africa Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 60 Saudi Arabia Swine Vaccines Market, 2018 - 2030 (USD Million)
Fig. 61 List of secondary sources
List Tables Figures
To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy